Skip to main content

Table 1 Baseline characteristics according to TyG index

From: Association between the triglyceride–glucose index and the risk of acute kidney injury in critically ill patients with acute pancreatitis: a retrospective study

 

Overall, N = 848

TyG indx < 8.78, N = 324

TyG index ≥ 8.78, N = 524

P value

Age, years

56.89 ± 16.76

59.82 ± 18.47

55.50 ± 16.21

 < 0.001

Sex(male)

497 (58.61%)

171 (52.78%)

326 (62.21%)

0.007

BMI

27.98 (24.13, 32.70)

27.13 (23.25, 31.56)

29.45 (25.29, 34.09)

 < 0.001

RBC,m/uL

4.12 ± 0.82

4.12 ± 0.74

4.13 ± 0.87

0.905

WBC,K/uL

9.20 (6.60, 13.50)

7.80 (5.90, 11.80)

8.55 (6.33, 12.08)

 < 0.001

Neutrophils,%

73.64 ± 14.83

73.32 ± 15.24

74.76 ± 15.02

0.600

Lymphocyte,%

17.21 ± 12.48

18.89 ± 13.02

16.19 ± 12.20

0.114

Hemoglobin,g/dL

12.55 ± 2.37

12.51 ± 2.23

12.58 ± 2.45

0.676

Platelets,(K/uL)

246.42 ± 123.64

253.21 ± 123.09

242.90 ± 122.23

0.178

TG,mg/dL

136.00 (90.00, 218.00)

85.00 (66.00, 105.00)

189 (140.00, 310.00)

 < 0.001

TC,mg/dL

163.00 (128.00, 203.00)

153.00 (122.00, 186.00)

175.00 (135.00, 219.00)

 < 0.001

Potassium, mmol/L

4.22 ± 0.79

4.17 ± 0.72

4.24 ± 0.82

0.189

Albumin,g/dL

3.55 ± 0.79

3.58 ± 0.78

3.53 ± 0.79

0.314

Total Bilirubin,mg/dL

23.60 ± 5.42

24.88 ± 4.91

22.90 ± 5.58

 < 0.001

Creatinine,mg/dL

1.00 (0.70, 1.40)

0.90 (0.70, 1.20)

1.00 (0.80, 1.50)

 < 0.001

ALT, U/L

32.25 (20.32, 75.80)

30.89 (18.91, 74.54)

33.87 (21.34, 78.09)

0.195

AST, U/L

42.21 (24.47, 103.98)

38.21 (24.36, 88.81)

46.02 (24.40, 107.82)

0.166

BUN, mg/dL

17.22 (12.87, 27.00)

16.62 (11.21, 23.80)

18.34 (12.18, 31.19)

0.003

Glucose,mg/dL

118.92 (96.35, 159.90)

100.52 (87.10, 118.89)

139.10 (107.23, 193.76)

 < 0.001

HDL, mg/dL

47.25 ± 24.01

55.50 ± 25.91

41.76 ± 21.52

 < 0.001

LDL, mg/dL

87.14 ± 36.27

82.92 ± 33.10

91.21 ± 38.33

0.004

ALP, U/L

91.26 (66.10, 144.50)

90.00 (66.28, 150.09)

91.10 (67.17, 143.25)

0.768

CRP, mg/L

18.19 (4.20, 79.03)

21.29 (4.10, 82.21)

16.21 (4.09, 68.27)

0.556

APSIII

47.00 (34.00, 66.00)

43.00 (33.00, 63.00)

49.00 (35.00, 67.00)

0.0037

SIRS

3.00 (2.00, 3.00)

3.00 (2.00, 3.00)

3.00 (2.00, 4.00)

0.005

SAPSIII

32.00 (23.00, 43.00)

31.00 (23.00, 41.00)

33.00 (22.00, 44.00)

0.705

SOFA

1.00 (0.00, 3.00)

1.00 (0.00, 3.00)

1.00 (0.00, 3.00)

0.145

Hypertension

217 (25.59%)

79 (24.38%)

138 (26.34%)

0.527

Atrial Fibrillation

174 (20.52%)

75 (23.15%)

99 (18.89%)

0.136

Myocardial Infarction

43 (5.07%)

11 (3.40%)

32 (6.11%)

0.080

COPD

88 (10.38%)

29 (8.95%)

59 (11.26%)

0.284

Diabetes

149 (17.59%)

54 (16.67%)

95 (18.13%)

0.241

RRT

103 (12.15%)

12 (3.70%)

91 (17.37%)

 < 0.001

CKD

80 (9.43%)

27 (8.33%)

53 (10.11%)

0.389

AKI

522 (61.56%)

179 (55.25%)

343 (65.46%)

0.003

In-hospital mortality

99(11.69%)

24 (7.41%)

75 (14.31%)

0.002

  1. Continuous variables were expressed as mean ± standard deviation (SD) for normally distributed variables, median (IQR) for non-normally distributed continuous variables, and numbers (%) for categorical variables. The T test or one-way ANOVA was used to compare continuous variables, while Pearson’s χ2 test was used to compare categorical variables when examining baseline characteristics
  2. BMI body mass index, RBC red blood cell, WBC white blood cell, TG triglyceride, TC total cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, BUN blood–urea–nitrogen, HDL high density lipoprotein cholesterol, LDL low density lipoprotein cholesterol, ALP alkaline phosphatase, CRP C-reactive protein, APSIII acute physiology score III, SIRS systemic inflammatory response syndrome score, SAPSII simplified acute physiology score II, SOFA sequential Organ Failure Assessment score, COPD Chronic obstructive pulmonary disease, RRT renal replacement therapy, CKD chronic kidney disease, AKI acute kidney injury
Back to article page

Journal of Intensive Care

ISSN: 2052-0492